GemVax&KAEL Co.,Ltd.

KOSDAQ:A082270 株式レポート

時価総額：₩398.1b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

GemVax&KAELLtd マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Sang-Jae Kim

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権2.6%
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

Risks To Shareholder Returns Are Elevated At These Prices For GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)

Jul 05
Risks To Shareholder Returns Are Elevated At These Prices For GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)

GemVax&KAELLtd's (KOSDAQ:082270) Earnings Are Weaker Than They Seem

Apr 03
GemVax&KAELLtd's (KOSDAQ:082270) Earnings Are Weaker Than They Seem

Is GemVax&KAELLtd (KOSDAQ:082270) A Risky Investment?

Feb 17
Is GemVax&KAELLtd (KOSDAQ:082270) A Risky Investment?

Investors Who Bought GemVax&KAELLtd (KOSDAQ:082270) Shares Three Years Ago Are Now Up 52%

Dec 26
Investors Who Bought GemVax&KAELLtd (KOSDAQ:082270) Shares Three Years Ago Are Now Up 52%

CEO（最高経営責任者

Sang-Jae Kim (58 yo)

no data

在職期間

Mr. Sang-Jae Kim serves as Chief Executive Officer at GemVax&KAEL Co.,Ltd. He serves as Co-Chief Executive Officer of BIOVILL Co.,Ltd. (formerly known as KSCB Co.,Ltd.) Mr. Kim serves as the Chief Executiv...